Story
1 Jan 2007
Rapport de responsabilité sociale des Entreprises du Médicament - engagements dans l’accès aux soins & médicaments, l’impact environnement, dialogue avec les parties prenantes
See all tags
See all tags
Abbott Laboratories
Bristol-Myers Squibb
Boehringer Ingelheim
Bayer
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Merck
Merck Sharp & Dohme (part of Merck)
Novartis
Novo Group
Novo Nordisk (part of Novo Group)
Pfizer
Procter & Gamble
Roche
Sanofi
Schering-Plough
Tibotec (part of Johnson & Johnson)
Wyeth (part of Pfizer)
Africa
Americas
Angola
Burkina Faso
Benin
Brazil
Botswana
Congo (the Democratic Republic of the)
Côte d'Ivoire
Cameroon
China
Costa Rica
Cuba
Dominican Republic
Egypt
Ethiopia
France
Guatemala
Haiti
Indonesia
India
Kenya
Cambodia
Comoros
Lebanon
Sri Lanka
Morocco
Madagascar
Mali
Mauritius
Malawi
Mozambique
Niger
Nigeria
Nicaragua
Peru
Philippines
Pakistan
Romania
Russia
Rwanda
Senegal
Chad
Thailand
Tanzania
Ukraine
Uganda
United States of America
Yemen
South Africa
Zimbabwe
People with Disabilities
Gender Discrimination
Racial, ethnicity, caste or origin discrimination
Restricted access to medicines
Illness
Labour Rights
Access to Water
Right to Privacy
WHO
Medical discrimination
Clean, Healthy & Sustainable Environment
Personal Health
People living with HIV/AIDs
Company Support for Initiatives Promoting Development, Economic and Social Rights